Picrocrocin

Picrocrocin: A Comprehensive Encyclopedic Reference

1. Identity: Chemical and Botanical Characterization

Chemical Identity

Picrocrocin is a monoterpene glycoside compound responsible for the characteristic bitter taste of saffron, chemically represented by the formula 4-(β-D-glucopyranosyl)-2,6,6-trimethylcyclohex-1-en-1-carboxaldehyde. Its molecular formula is C₁₆H₂₆O₇ and its molecular weight is 330.37 g/mol; it is a colorless monoterpene glycoside and the precursor of safranal. The compound is registered under CAS number 138-55-6. Its UV maximum absorbance is at 254 nm.

Botanical Source

Among the oxidation products of carotenoids in saffron, picrocrocin is one of two key compounds — along with safranal — that define the spice's bitterness and aromatic strength respectively. Crocus sativus L. belongs to the Iridaceae family and is commonly known as saffron. It is a perennial, stemless herb cultivated in most Mediterranean countries and in Iran, India, and China. Botanically, C. sativus is a sterile, triploid selection (cultigen) propagated by dividing corms, not by seed.

Picrocrocin is formed by the oxidative breakdown of the carotenoid zeaxanthin. It makes up approximately 4% of the mass of dry saffron and is a glucoside derivative of safranal. More precisely, it is the second most abundant saffron component, comprising approximately 1–13% of saffron's dry matter. Geographic origin strongly influences this range: picrocrocin content in saffron from Iran has been found to be 2.18–6.15%, from India 1.07–2.16%, and from Spain 0.79–12.94%.

Relationship to Safranal and Biosynthesis

During the drying process, the β-glucosidase enzyme acts on picrocrocin to release 4-hydroxy-2,6,6-trimethyl-1-cyclohexene-1-carboxyaldehyde (HTCC, C₁₀H₁₆O₂), which upon dehydration is transformed into safranal (C₁₀H₁₄O). Fresh saffron samples contain a higher concentration of crocins and picrocrocins, whereas the level of safranal is higher in stored or dried samples; the relationship between aging/drying time and safranal content is well documented.

Common Forms and Preparations

Picrocrocin is not typically isolated and administered as a standalone supplement. It is predominantly encountered as an inherent constituent of the whole dried saffron stigma (Crocus sativus L.) or in standardized saffron extracts. Saffron is one of the oldest natural food supplements, with the glycosylated apocarotenoid picrocrocin accumulated specifically in plant stigmas. Preparations in which picrocrocin is present include:

• Dried saffron threads (stigmas): The traditional whole-spice form, consumed in culinary or medicinal infusions.
• Aqueous extracts and infusions: Hot-water preparations used traditionally and in numerous research studies.
• Standardized saffron powder and capsules: Saffron is used not only as a food raw material or spice, but also as a medicinal raw material.
• Ethanolic extracts: Used in pharmacological and in vitro research settings.
• Isolated picrocrocin working standards: HPTLC methods for picrocrocin quantification have been validated; preparative chromatography has been used to obtain working standards of picrocrocin and crocins from saffron samples.

Quality Standardization

The international standard ISO 3632 outlines spectrophotometric procedures to determine the concentrations of key chemical markers, including picrocrocin (taste), crocin (color), and safranal (aroma), as well as other parameters such as moisture content and extraneous matter, for consistent and objective classification of saffron into Category I, II, or III. Category I — the highest grade — requires a minimum crocin absorbance of 190, picrocrocin above 70, and safranal between 20–50 on the E_1% scale. All saffron samples evaluated for pharmaceutical use are pre-tested according to ISO 3632 and European Pharmacopoeia requirements to confirm quality and safe use.

2. Traditional and Historical Use

Ancient Origins

Saffron has been used since the Stone Age; traces of saffron pigment have been demonstrated by modern methods in a prehistoric cave in Iraq and in wall paintings in Santorini (Greece). These fresco paintings in Santorini are 3,000–5,000 years old and depict saffron scenes, including a woman with a wounded foot placed on a crocus flower, suggesting medicinal use.

The oldest documents concerning the edible use of saffron are recorded by Polyen in the 2nd century BC, who references a list of foods consumed at the court of the Persian Achemenide dynasty (550–330 BC). For over three millennia it was cultivated across the Mediterranean, including ancient Greece, Persia, and other cultures, later spreading worldwide.

Persia (Iran)

Saffron was highly regarded in ancient Persia for its medicinal properties and was extensively used in traditional medicine. In Persia, in Isfahan and Khorasan, saffron was cultivated as far back as the 10th century BC. At such sites, saffron threads were woven into textiles, ritually offered to divinities, and used in dyes, perfumes, medicines, and body washes.

Ancient Greece and Rome

Saffron is featured in trade lists from Mari, Syria, is described in a 7th-century BC Assyrian botanical reference compiled under Ashurbanipal, and is listed among other aromatic plants in the Hebrew Bible. During his Asian campaigns, Alexander the Great used Persian saffron in his infusions, rice, and baths as a curative for battle wounds; his troops imitated the practice from the Persians and brought saffron-bathing to Greece. In ancient Rome, saffron was used as medicine and perfume.

Ayurvedic, Unani, and Asian Traditions

Throughout Asia, saffron was widely employed in Ayurvedic medicine to address various health issues, including digestive disorders, inflammation, and mood disturbances. Zafran (saffron) is a highly valued Unani medication that has been shown to improve immunological function, neuroprotection, mood enhancement, and heart health, due to active components including picrocrocin.

In traditional medicine, saffron (and therefore its constituent picrocrocin as part of the whole stigma preparation) was used as an aphrodisiac, antispasmodic, expectorant, and remedy for stomachache, tension, depression, and insomnia. The powdered stigma was also applied in the treatment of cataract. Other traditional applications included antibacterial, antiseptic, and antifungal uses.

When Persian traders introduced saffron to the Indian subcontinent, the Kashmir region became known for producing high-quality saffron, prized for its deep color and potent aroma. Books of ancient Chinese sages describe saffron as a miraculous medicinal remedy.

Note on Traditional Use of Picrocrocin Specifically

It is important to note that historical and traditional medicine employed the whole dried saffron stigma — not isolated picrocrocin. Picrocrocin as an isolated compound was only characterized in the modern era. All historical use attributes to the complex mixture of compounds in the intact stigma, of which picrocrocin is one of the three defining chemical markers along with crocin and safranal.

3. Chemical Constituents and Context Within Saffron

The Major Bioactive Triad

Beyond minerals, proteins, sugars, and vitamins such as B1 and B2, saffron possesses four main bioactive ingredients: crocin, crocetin, picrocrocin, and safranal. Crocin and crocetin are carotenoid compounds responsible for saffron's yellow color; picrocrocin is responsible for the flavor and bitterness, while safranal is responsible for its characteristic odor.

Since the first phytochemical report on saffron by Zarghami in 1971, together with the development and advancement of chromatography, the phytochemical profile of saffron has been extensively studied; to date, more than 150 volatile and non-volatile compounds have been identified, with about 60 characterized by conventional isolation and structural elucidation.

Picrocrocin Among the Saffron Compounds

Several active ingredients are present in saffron, including carotenoids (crocin, crocetin), monoterpene aldehydes (picrocrocin, safranal), monoterpenoids (crocusatines), isophorones, and flavonoids. Other components include flavonoids, anthocyanins, vitamins such as riboflavin and thiamine, proteins, starch, amino acids, mineral matter, and gums.

Sensory Role and Taste Threshold

A systematic approach on the bitterness of picrocrocin, the major compound responsible for saffron's bitter taste, established that the detection threshold is 5.34 mg/L and the recognition threshold is 7.26 mg/L, using the Ascending Forced Choice of Limits methodology. These threshold values were examined in water in the absence and presence of other saffron constituents and ethanol and were found to decrease when served hot (61 ± 4 °C). Bitterness was enhanced in 40% (v/v) aqueous ethanol, and in both aqueous and ethanol extracts, the presence of saffron volatiles improved bitterness perception.

4. Mechanisms of Action

Antioxidant and Free-Radical Scavenging Activity

As a major bioactive compound of saffron, picrocrocin has valuable medicinal properties, particularly anticancer effects. Picrocrocin as a component of saffron displays antitumor activity with great potential for the prevention and treatment of various cancers through affecting cellular DNA and RNA synthesis and free radical scavenging activities. Studies of antioxidant activity using three methods — DPPH, FRAP, and total antioxidant capacity — have demonstrated that C. sativus is a potential source of natural antioxidants.

Anticancer Mechanisms

Various mechanisms have been described for the antitumor effects of saffron and its ingredients: (a) promotion of cell cycle arrest, (b) inhibition of DNA and RNA synthesis, (c) ability to scavenge free radicals, (d) involvement in the metabolic conversion of carotenoids to retinoids, (e) direct or indirect interactions with topoisomerase II, (f) promotion of interactions mediated via lectins, and (g) downmodulation of specific signaling pathways.

Saffron appears to have selective toxicity against cancer cells through various mechanisms, including inhibition of RNA and DNA synthesis and increasing apoptosis and protein synthesis. Certain gene pathways related to cell apoptosis induction and proliferation inhibition are considered the major antitumor mechanism.

Gastroprotective Effects

Pharmacological properties of picrocrocin, such as its stomach-protective and appetite-stimulating effects, have been explored in scientific studies. As a bitter compound, picrocrocin may contribute to appetite stimulation through classical bitterant mechanisms, which are thought to promote gastric secretion and digestive function, although specific mechanistic studies isolating this effect to picrocrocin alone remain limited.

Insecticidal Properties

Picrocrocin with insecticidal properties is one of the characteristic features of saffron. This property is considered to contribute to the plant's ecological defense strategy.

5. Scientific Evidence by Area of Use

Important framing note: The vast majority of research on picrocrocin has been conducted in the context of the whole saffron stigma or saffron extract. Studies specifically isolating the pharmacological effects of picrocrocin — distinct from crocin, crocetin, and safranal — are limited in number and are predominantly in vitro (cell culture) or preclinical (animal). There are presently no registered clinical trials studying isolated picrocrocin as a therapeutic agent. All clinical evidence discussed below pertains to saffron (the whole stigma or its extract) in which picrocrocin is one of the active constituents.

5.1 Anticancer Activity

In Vitro Evidence (Direct Picrocrocin Studies)

Extracts of saffron have been reported to inhibit cell growth of human tumor cells. In a landmark in vitro study by Escribano et al., crocin, crocetin, picrocrocin, and safranal were isolated and individually tested. Doses inducing 50% cell growth inhibition (LD₅₀) on HeLa cervical carcinoma cells were: 2.3 mg/ml for an ethanolic extract of saffron dry stigmas, 3 mM for crocin, 0.8 mM for safranal, and 3 mM for picrocrocin. Crocetin did not show a cytotoxic effect. Crocin showed the strongest inhibitory effect; the inhibitory effects of the ethanol extract were mainly attributed to crocin. Picrocrocin and safranal had minor effects (ID₅₀ was 3 and 0.8 mM, respectively).

Experiments studying the effect of picrocrocin on the proliferation of human tumoral HeLa cells in vitro showed that picrocrocin has a dose-dependent inhibition of cell growth, with the dose inducing 50% inhibition of HeLa cell growth being 3 mM, with minor cytotoxicity for normal cells.

Aqueous extracts of saffron were tested for their effect on cell viability in normal human lung fibroblasts and several human malignant cell lines (MCF-7, SKNH, and HeLa). While saffron extracts produced no changes in cell viability of normal human lung fibroblasts, a dose-dependent inhibitory effect was observed on malignant cells.

Evidence Strength: Preclinical/in vitro only for picrocrocin as an isolated compound. The cytotoxic activity of picrocrocin against HeLa cells is documented, but picrocrocin is notably less potent than crocin or safranal in these assays. No human clinical trials of isolated picrocrocin in oncology have been identified.

5.2 Neuropsychiatric and Neuroprotective Effects

Preclinical Evidence

Saffron, which contains picrocrocin as a key constituent, has been tested in preclinical and clinical trials of depression, anxiety, Alzheimer's disease, and other brain disorders. Active ingredients present in saffron include carotenoids (crocin, crocetin) and monoterpene aldehydes (picrocrocin, safranal), among others.

Clinical Evidence (Whole Saffron / Saffron Extract)

Clinical trials suggest that the effectiveness of saffron in treating mild to moderate depression is comparable to that of standard medications, and animal studies support these results, showing behavioral improvements with saffron treatment. The most commonly studied clinical dose in depression trials has been saffron extract standardized to approximately 30 mg/day. In randomized double-blind clinical trials performed on patients with a mixed anxiety–major depressive disorder (MDD) diagnosed by DSM IV or V, one study used a much higher dose (approximately 3-fold more than the usual doses of 30 mg/day) of dried stigmas, with a significant difference found between treatment and placebo in both anxiety and depression scores.

Both preclinical and clinical trials have suggested that saffron is effective and safe without serious side effects, and that its bioactive compounds have multiple therapeutic effects in conditions including psychological disorders, neurodegenerative diseases, cancer, diabetes, and cardiovascular diseases.

Evidence Strength: Moderate for whole saffron extract in mild-to-moderate depression (multiple RCTs). The specific contribution of picrocrocin to the neuroprotective and antidepressant effects, as distinct from crocin, crocetin, or safranal, has not been isolated in clinical investigations. Evidence is preliminary for neuroprotection specifically attributable to picrocrocin.

5.3 Antioxidant Activity

The chemical composition of saffron stigmas, related to primary and secondary metabolites, makes saffron a rich source of distinct bioactive compounds with pronounced antioxidant properties. Among them, crocin, crocetin, picrocrocin, and safranal are the most important contributors to saffron's sensory properties and antioxidant potential. Literature data suggest that stigmas possess great antioxidant potential expressed through in vitro and in vivo assays.

Evidence Strength: Strong for the whole saffron extract. Antioxidant activity specifically attributable to isolated picrocrocin is supported by in vitro data, but picrocrocin's contribution relative to co-occurring crocin/crocetin is considered secondary based on current comparative evidence.

5.4 Gastrointestinal and Appetite Effects

Pharmacological properties of picrocrocin, such as its stomach-protective and appetite-stimulating effects, have been explored in scientific studies. As a bitter glycoside, picrocrocin is the primary compound responsible for saffron's characteristically bitter taste, and bitterness in plant-based medicines has long been associated with stimulating gastric secretion and appetite. In traditional medicine, the whole saffron preparation was used for stomachache and related gastrointestinal complaints.

Evidence Strength: Preclinical and traditional use only. No specific clinical trials of isolated picrocrocin for gastrointestinal indications have been identified.

5.5 Antimicrobial Activity

Antimicrobial activity of aqueous C. sativus extract has been investigated by microdilution on a microplate, revealing efficacy against Acinetobacter baumannii and Shigella sp. with MIC ≤ 600 µg/mL, and against Aspergillus niger, Candida kyfer, and Candida parapsilosis with MIC = 2500 µg/mL. This evidence, however, pertains to whole saffron extract, not isolated picrocrocin.

Evidence Strength: Preliminary in vitro evidence for the whole extract. The role of picrocrocin in particular is not yet independently established.

5.6 Cardiovascular and Metabolic Effects

Results of animal studies confirm the antioxidant, anti-inflammatory, anticancer, antidiabetic, and antihypertensive activities of saffron. Pharmacological activities studied in saffron stigma extracts and individual phytochemicals include antioxidant, antiparasitic, hypolipidemic, antihypertensive, immunomodulatory, antimicrobial, antitumor, cytotoxic, and antidepressant effects.

Evidence Strength: Predominantly preclinical for cardiovascular effects. Clinical evidence refers to whole saffron preparations; isolation of picrocrocin's specific cardiovascular contribution has not been demonstrated in human studies.

6. Body Systems and Health Areas Associated with Picrocrocin (as Part of Saffron)

• Central Nervous System: In modern medicine, pharmacological properties of the saffron stigma including neuroprotective, antitussive, hypolipidemic, anticonvulsant, antinociceptive, antidepressant, anxiolytic, cardiovascular protective, anticancer, and antioxidant activity have been reported.
• Oncology (Preclinical): In vitro inhibition of cancer cell proliferation (HeLa, MCF-7, SKNH), attributed in part to picrocrocin's ability to inhibit DNA/RNA synthesis and induce apoptosis at high concentrations.
• Gastrointestinal System: Traditional use for gastric complaints; picrocrocin's bitter taste is associated with bitterant-mediated digestive stimulation.
• Cardiovascular System: Antihypertensive and hypolipidemic properties attributed to the saffron complex.
• Immune System: The immunomodulatory properties of saffron constituents have been considered potentially effective against inflammatory and immune system disorders via modulation of related pathways.
• Sensory / Taste: Picrocrocin is the defining compound for saffron's bitter taste and is the direct biosynthetic precursor to safranal, saffron's primary odorant.

7. Dosage Forms and Dosages Reported in Studies

Picrocrocin is not commercially available as a standalone dietary supplement with its own dosage guidelines. The following dosage information reflects preparations of saffron in which picrocrocin is a constituent, as reported in scientific literature and quality standards.

• Whole saffron (culinary/traditional): Typical culinary use involves a few threads (milligram-range amounts of total saffron). Daily consumption of saffron up to 1.5 g/day has not been found to be associated with any adverse effect.
• Standardized saffron extract (clinical studies in depression): The most commonly reported dose in clinical trials of depression is approximately 30 mg/day, with at least one trial using approximately 3-fold this dose (approximately 90 mg/day of dried stigmas) in a 12-week protocol.
• In vitro anticancer studies — picrocrocin specifically: The dose inducing 50% cell growth inhibition (LD₅₀) on HeLa cells was 3 mM for picrocrocin. These are laboratory concentrations and cannot be directly translated to human doses.
• Sensory bitterness threshold: The taste detection threshold of picrocrocin was found to be 5.34 mg/L and the recognition threshold 7.26 mg/L.
• ISO 3632 quality categorization (minimum picrocrocin value): Category I (the highest grade) requires picrocrocin absorbance above 70 on the E_1% scale.

8. Safety Considerations and Known Interactions

General Safety Profile

In vivo studies have revealed that saffron has negligible toxicity at normal consumption levels. The oral LD₅₀ of saffron decoction in mice has been reported to be 20.7 g/kg. Oral administration of saffron extract at doses between 0.1–5.0 g/kg has been reported as non-toxic in mouse models. Clinical data on toxicity and safety are inconsistent; however, daily consumption up to 1.5 g/day in humans has not been found to be associated with adverse effects, while doses higher than 5 g are considered toxic and doses of 20 g are considered lethal.

Dose-Dependent Toxicity

Doses of 5 g are associated with toxic effects; doses of 10 to 20 g may be fatal. Severe adverse effects, including purpura, thrombocytopenia, and severe bleeding, have been reported after ingestion of saffron at 5 g. Saffron doses over 10 g have been used historically for abortion with high risk of maternal death; at such doses, saffron can induce vomiting, uterine bleeding, hematuria, gastrointestinal bleeding, and vertigo.

Uterine Stimulant Effects and Pregnancy

Use of saffron in amounts higher than those used in food (e.g., 5 g or more) has been associated with uterine stimulant and abortifacient effects. One of the main concerns about saffron consumption during pregnancy is its impact on uterine muscle contractions; laboratory and animal studies have shown that saffron extract and its active compounds can increase contractions of the smooth muscles of the uterus.

Picrocrocin's Specific Safety Profile

Picrocrocin is the least studied of the three major compounds in terms of isolated toxicity, but it contributes to the bitterness that naturally limits overconsumption of whole saffron in food. If taken on a completely empty stomach, the bitter compounds including picrocrocin can cause mild nausea or stomach cramping.

Adverse Effects of Saffron

Reported adverse effects of saffron include nausea, vomiting, and headache. Allergic reactions are uncommon; however, occupational allergies, including rhinoconjunctivitis, bronchial asthma, and cutaneous pruritus, have been reported. Case reports of anaphylaxis also exist.

Drug Interactions

Saffron can interact with blood thinners (potentially increasing bleeding risk), blood pressure medications (potentially causing severe hypotension), diabetes medications (potentially causing low blood sugar), and sedatives (potentially causing excessive drowsiness). These interactions pertain to the whole saffron preparation; the extent to which picrocrocin specifically contributes to each interaction has not been individually characterized.

Mutagenicity

A few studies have evaluated the mutagenicity of saffron using the Ames Salmonella assay; available evidence has not found mutagenic activity at culinary or low therapeutic doses, though formal genotoxicity data specifically for isolated picrocrocin remain sparse.

9. Research Gaps and Current Status

Despite picrocrocin's recognized role as a key chemical marker of saffron quality and a compound with demonstrable in vitro biological activity, it remains considerably less studied as an isolated agent than crocin or safranal. The anti-tumor effects of saffron and its bioactive components, crocins, crocetin, safranal, and picrocrocin, isolated from the stigma of saffron, have been extensively explored only in recent decades. Key gaps include: (1) no human clinical trials of isolated picrocrocin exist; (2) the pharmacokinetics of picrocrocin in humans — absorption, distribution, metabolism, and excretion — are poorly characterized; (3) the precise molecular targets mediating picrocrocin's bitterant, anticancer, and gastroprotective effects require further elucidation; and (4) synergistic interactions between picrocrocin and co-occurring saffron constituents (particularly crocin and safranal) have not been comprehensively mapped in clinical settings. The contents of active compounds in saffron also vary from region to region, adding further complexity to standardization of any picrocrocin-containing preparation for therapeutic use.

References

• Carmona et al. (2015). Sensory Threshold Studies of Picrocrocin, the Major Bitter Compound of Saffron. PubMed.
• Picrocrocin — an overview. ScienceDirect Topics.
• Picrocrocin (Chemistry) — an overview. ScienceDirect Topics.
• Saffron: Chemical Composition and Neuroprotective Activity. PMC (2020).
• The toxicity of saffron (Crocus sativus L.) and its constituents against normal and cancer cells. ScienceDirect (2015).
• Escribano et al. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Letters / ScienceDirect.
• Saffron (Crocus sativus) petal as a new pharmacological target: a review. PMC (2018).
• A review of therapeutic impacts of saffron (Crocus sativus L.) and its constituents. PMC (2023).
• Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside. PMC / Frontiers in Pharmacology (2020).
• Saffron and its active ingredients against human disorders: A literature review on existing clinical evidence. PMC (2022).
• Exploring the Potential of Saffron as a Therapeutic Agent in Depression Treatment: A Comparative Review. PMC (2024).
• From Mood to Memory: Unlocking Saffron's Potential in Brain Health. PMC (2025).
• Effective Isolation of Picrocrocin and Crocins from Saffron: From HPTLC to Working Standard Obtaining. PMC (2022).
• Identification of Compounds of Crocus sativus by GC-MS and HPLC/UV-ESI-MS and Evaluation of Their Antioxidant, Antimicrobial, Anticoagulant, and Antidiabetic Properties. PMC (2023).
• Effect of Crocus sativus L. Stigmas Microwave Dehydration on Picrocrocin, Safranal and Crocetin Esters. PMC (2021).
• Tung et al. A narrative review of phytochemical profile of Saffron and principal crocetin glycosides. Longhua Chinese Medicine (2022).
• Wenger. History of Saffron. Longhua Chinese Medicine (2022).
• Chemical Composition and Quality of Saffron. Encyclopedia MDPI.
• The Chemistry of Saffron (Crocus Sativus L.): Nature's Red Gold. Oriental Journal of Chemistry (2025).
• Crocus Sativus — an overview. ScienceDirect Topics.
• Composition of crocins and picrocrocin from Spanish saffron (Crocus sativus L.). ResearchGate.
• Saffron Uses, Benefits & Dosage. Drugs.com Natural Products Database.
• In vitro micropropagation and apocarotenoid gene expression in saffron (includes toxicity review). arXiv (2022).
• Hasheminasab et al. Adverse Events of Saffron (Crocus sativus L.): Systematic Review of Current Evidence. Health Science Reports / Wiley (2026).
• Saffron: Medicine, Tradition, and the Women Who Sustain Its Ancient Knowledge. Center for Traditional Medicine (2026).
• Phytochemistry, Biological Activities, Molecular Mechanisms, and Toxicity of Saffron (Crocus sativus L.): A Comprehensive Overview. MDPI Antioxidants (2025).
• Crocetin Esters, Picrocrocin and Its Related Compounds Present in Crocus sativus Stigmas and Gardenia jasminoides Fruits. Journal of Agricultural and Food Chemistry, ACS.